Vaccinex Inc (VCNX)
6.20
+0.20
(+3.33%)
USD |
NASDAQ |
May 02, 16:00
6.20
0.00 (0.00%)
After-Hours: 17:43
Vaccinex Cash from Operations (TTM): -17.23M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -17.23M |
September 30, 2023 | -18.24M |
June 30, 2023 | -19.29M |
March 31, 2023 | -19.12M |
December 31, 2022 | -19.07M |
September 30, 2022 | -19.62M |
June 30, 2022 | -21.53M |
March 31, 2022 | -23.18M |
December 31, 2021 | -25.30M |
September 30, 2021 | -26.54M |
June 30, 2021 | -29.78M |
March 31, 2021 | -28.25M |
December 31, 2020 | -28.65M |
Date | Value |
---|---|
September 30, 2020 | -28.07M |
June 30, 2020 | -29.25M |
March 31, 2020 | -29.75M |
December 31, 2019 | -30.72M |
September 30, 2019 | -32.47M |
June 30, 2019 | -29.20M |
March 31, 2019 | -28.59M |
December 31, 2018 | -25.28M |
September 30, 2018 | -23.97M |
June 30, 2018 | -21.48M |
March 31, 2018 | -21.92M |
December 31, 2017 | -21.39M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-32.47M
Minimum
Sep 2019
-17.23M
Maximum
Dec 2023
-25.01M
Average
-26.54M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Emergent BioSolutions Inc | -206.30M |
Avinger Inc | -14.43M |
RAPT Therapeutics Inc | -97.05M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |